MYC and non-Hodgkin lymphoma: Downregulation of MCL1 mRNA in patients with DH-DLBCL and other MYC+ NHL on C1D15 was 45.81% (range, 30%–55.5%) and 18.27% (range, 0%–43.1%), respectively.